Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
批准号:
9884542
负责人:
ALAN K LICHTENSTEIN
金额:
$28.82万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-17 至 2022-02-28
关键词:
5&apos Untranslated RegionsAcuteBindingBortezomibCategoriesCell NucleusCell ProliferationCell SurvivalCellsCessation of lifeComplexCytoplasmDNADataDepressed moodDevelopmentDrug usageEventFRAP1 geneFeedbackFundingFutureGenetic TranscriptionGoalsHybridsInitiator CodonInterleukin-6Internal Ribosome Entry SiteLibrariesMalignant - descriptorMalignant NeoplasmsMediatingMessenger RNAModelingModificationMolecular ConformationMultiple MyelomaOncoproteinsPathway interactionsPhosphorylationPhosphotransferasesPlasma CellsProductionProteinsRNA-Binding ProteinsRegulationRibosomal ProteinsRibosomesRiskRoleTestingTherapeuticTrans-ActivatorsTranslationsWorkYeastsc-myc Genesdesigndrug developmentendoplasmic reticulum stressexperimental studyhnRNP A1in vitro activityin vivoinhibitor/antagonistmTOR Inhibitormouse modelneoplastic cellpreventprotein expressionrecruitresponsesmall molecule inhibitortherapeutic targettranscription factortumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The main objective of this project is to provide a rationale for future therapeutic targeting of the c-myc IRES
which mediates cap-independent translation in multiple myeloma cells. IRES-dependent myc translation is
critical for tumor cell survival during ER stress in this tumor model. The aims include studying the mechanism
by which the MNK kinase, the hnRNP A1 ITAF and the ribosomal protein RPS25 mediate IRES function; the
mechanism and importance of myc inducing A1 and RPS25 expression and the potential for an inhibitor of
IRES function in myeloma. The viability versus death of myeloma cells as well as their ability to achieve c-myc
translation and IRES activity in vitro will be studied. In addition, a murine model of c-myc-driven myeloma will
be exploited to determine the in vivo roles of hnRNPA1 and IRES activity in tumor progression as well as the
potential efficacy of our IRES inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting DEPTOR in multiple myeloma
-
批准号:10219172
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2017
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
-
批准号:9277218
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2017
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting DEPTOR in multiple myeloma
-
批准号:9977974
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2017
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting DEPTOR in multiple myeloma
-
批准号:8442174
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2013
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting DEPTOR in multiple myeloma
-
批准号:8601298
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2013
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting TORC2 in Multiple Myeloma
-
批准号:8762435
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting TORC2 in Multiple Myeloma
-
批准号:8330231
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting of DEPTOR in Multiple Myeloma
-
批准号:9335141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting TORC2 in Multiple Myeloma
-
批准号:8597941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Targeting TORC2 in Multiple Myeloma
-
批准号:8963450
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Use of CCI-779 in multiple myeloma
-
批准号:7666888
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2008
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Use of CCI-779 in multiple myeloma
-
批准号:7382380
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2008
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors
-
批准号:7068601
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity of multiple myeloma cells to mTOR inhibitors
-
批准号:8857105
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
EBV lytic re-activation in nasopharyngeal carcinoma
-
批准号:6936975
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
EBV lytic re-activation in nasopharyngeal carcinoma
-
批准号:7070509
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity of multiple myeloma cells to mTOR inhibitors
-
批准号:8284978
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors
-
批准号:7591111
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors
-
批准号:7408112
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
Sensitivity of multiple myeloma cells to mTOR inhibitors
-
批准号:8484360
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2005
-
负责人:ALAN K LICHTENSTEIN
-
依托单位:
海外基金